Stroke News and Research

RSS

A stroke is a medical emergency. Strokes happen when blood flow to your brain stops. Within minutes, brain cells begin to die. There are two kinds of stroke. The more common kind, called ischemic stroke, is caused by a blood clot that blocks or plugs a blood vessel in the brain. The other kind, called hemorrhagic stroke, is caused by a blood vessel that breaks and bleeds into the brain. "Mini-strokes" or transient ischemic attacks (TIAs), occur when the blood supply to the brain is briefly interrupted.

New tool helps doctors assess likelihood of death from stroke

Researchers at St. Michael's Hospital and the Institute for Clinical and Evaluative Sciences (ICES) in Toronto have developed a new tool that will help doctors predict the probability of death in patients after an ischemic stroke.

11 Feb 2011

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Medical researchers from The University of Texas Health Science Center at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem-, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.

11 Feb 2011

Calorie Control Council: Study showing association between diet soft drink, stroke risk is critically flawed

The Calorie Control Council stated today that research findings presented during a poster session at the International Stroke Conference claiming an association between diet soft drink consumption and increased risk of stroke and heart attack are critically flawed.

11 Feb 2011

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

New findings from a McMaster University-led study of a drug recently identified to prevent stroke in patients with atrial fibrillation have been published in the high-impact New England Journal of Medicine today.

11 Feb 2011

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

Neuralstem, Inc. updated the progress of its ongoing Phase I human clinical trial of the company's spinal cord stem cells in the treatment of ALS (amyotrophic lateral sclerosis, or Lou Gehrig's disease) at Emory University in Atlanta, Georgia.

11 Feb 2011

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

Alexion Pharmaceuticals, Inc. today announced financial results for the quarter and year ended December 31, 2010. For the three months ended December 31, 2010, Alexion Pharmaceuticals, Inc. reported net product sales of Soliris® (eculizumab) of $156.0 million, reflecting strong additions of new patients, compared to $110.6 million for the same period in 2009.

10 Feb 2011

International Stroke Conference: News releases and news tips

Government researcher receives top honor, five others recognized at stroke conference

10 Feb 2011

Lakewood Regional Medical Center supports 'Focus on the Heart' campaign

With approximately one death occurring every 36 seconds from cardiovascular disease, Americans need to find a way to beat the odds. That premise is the impetus behind Lakewood Regional Medical Center's new campaign, which encourages the community to "Focus on the Heart" by undergoing regular screenings and adopting a heart-healthy lifestyle.

10 Feb 2011

Study: New curcumin-hybrid compound may help protect, regenerate brain cells after stroke

Whether or not you're fond of Indian, Southeast Asian and Middle Eastern food, stroke researchers at Cedars-Sinai Medical Center think you may become a fan of one of their key spices.

10 Feb 2011

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

Neuralstem, Inc. announced that the U.S. Food and Drug Administration's Office of Orphan Products Development has granted it orphan drug designation for the treatment of Amyotrophic Lateral Sclerosis (ALS) with its human spinal cord derived neural stem cells (NSI-566RSC), currently in a Phase I safety study to evaluate the safety of the product and the surgical route of administration in a wide range of ALS patients.

10 Feb 2011

People with memory problems may face high risk of stroke

People who have memory problems or other declines in their mental abilities may be at higher risk for stroke, according to a study released today that will be presented at the American Academy of Neurology's 63rd Annual Meeting in Honolulu April 9 to April 16, 2011.

9 Feb 2011

Over 45 telemedicine networks under management of InTouch Health

InTouch Health® today announced that more than 45 telemedicine networks are currently under management. In total, these networks represent 475 contracted hospital locations where 375 are delivering telemedicine clinical services and the remaining 100 are undergoing pre-installation planning. InTouch Health provides complete telemedicine solutions that allow physicians to remotely perform real-time consults with hospital patients.

9 Feb 2011

Two new studies report GOT may improve health outcomes of stroke patients

Much of the devastation of stroke and head trauma is due to damage caused the overproduction of a substance in the brain called glutamate. Preventing this damage has been impossible, until now, as many drugs don't cross the so-called blood-brain barrier, and those that do often don't work as intended. But a method originally devised at the Weizmann Institute of Science may, in the future, offer a way to avert such glutamate-induced harm.

9 Feb 2011

Life Sciences Discovery Fund announces nearly $600,000 in awards

The Life Sciences Discovery Fund (LSDF) today announced nearly $600,000 in awards to support commercial development of technologies to improve the diagnosis and management of major health conditions.

9 Feb 2011

BeneChill, Physio-Control to launch RhinoChill IntraNasal Cooling System in Europe

Physio-Control, a global leader in emergency medical solutions and wholly-owned subsidiary of Medtronic, and BeneChill, a pioneer in portable therapeutic cooling systems, today announced a strategic partnership to launch the RhinoChill IntraNasal Cooling System in Europe.

9 Feb 2011

UW research receives Keck Foundation grant to restore lost brain function using neurochips

Tiny, implantable computers that would restore brain function lost to disease or injury is the goal of University of Washington research recently funded by a $1 million, three-year grant from the W.M. Keck Foundation.

9 Feb 2011

FDA proposes new Innovation Pathway program for pioneering medical devices

Today the U.S. Food and Drug Administration proposed the Innovation Pathway, a priority review program for new, breakthrough medical devices and announced the first submission: a brain-controlled, upper-extremity prosthetic that will serve as a pilot for the program. The FDA also announced plans to seek further public comment before the Pathway can be used more broadly.

9 Feb 2011

DE-MRI holds promise for predicting risks of strokes

Researchers at the University of Utah's Comprehensive Arrhythmia and Research Management Center have found that delayed-enhancement magnetic resonance imaging holds promise for predicting the risks of strokes, the third leading cause of death in the U.S.

9 Feb 2011

Prolonged sleep deprivation can lead to long-term, serious health implications

New research from Warwick Medical School published today in the European Heart Journal shows that prolonged sleep deprivation and disrupted sleep patterns can have long-term, serious health implications. Leading academics from the University have linked lack of sleep to strokes, heart attacks and cardiovascular disorders which often result in early death.

9 Feb 2011

Physician offers tips to kick-off heart disease and its risk factors

The health statistics are heart-stopping for Hispanic communities: the leading cause of death among both Hispanic men and women is cardiovascular disease.

9 Feb 2011

Stroke News and Research

Further Reading

New tool helps doctors assess likelihood of death from stroke

Athersys' MultiStem cell therapy provides multiple benefits in preclinical models of ischemic stroke

Calorie Control Council: Study showing association between diet soft drink, stroke risk is critically flawed

New findings of drug recently identified to prevent stroke in patients with AF published in NEJM

Neuralstem updates progress of ongoing clinical trial of spinal cord stem cells in treatment of ALS

Alexion fourth quarter net product sales of Soliris increases to $156.0 million

International Stroke Conference: News releases and news tips

Lakewood Regional Medical Center supports 'Focus on the Heart' campaign

Study: New curcumin-hybrid compound may help protect, regenerate brain cells after stroke

FDA grants Neuralstem orphan drug designation for treatment of ALS with spinal cord stem cells

People with memory problems may face high risk of stroke

Over 45 telemedicine networks under management of InTouch Health

Two new studies report GOT may improve health outcomes of stroke patients

Life Sciences Discovery Fund announces nearly $600,000 in awards

BeneChill, Physio-Control to launch RhinoChill IntraNasal Cooling System in Europe

UW research receives Keck Foundation grant to restore lost brain function using neurochips

FDA proposes new Innovation Pathway program for pioneering medical devices

DE-MRI holds promise for predicting risks of strokes

Prolonged sleep deprivation can lead to long-term, serious health implications

Physician offers tips to kick-off heart disease and its risk factors

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News